Novel Coronavirus (SARS-CoV-2/COVID-19)

Please contact your representatives today and ask them sign on to a 鈥淒ear Colleague鈥 letter to the Department of Health and Human Services (HHS) urging it to reinstate the COVID-19 Provider Relief Fund (PRF) reporting requirements outlined in HHS鈥 June 19 FAQ that defined both expenses and lost鈥
The Centers for Medicare & Medicaid Services Oct. 9 announced a crackdown on labs that are testing for COVID-19 without proper Clinical Laboratory Improvement Amendments certification.
The Department of Health and Human Services and Department of Defense Oct. 9 announced support for AstraZeneca鈥檚 late-stage development and large-scale manufacturing of the AZD7442 investigational treatment for COVID-19.
We know that prior to the COVID-19 outbreak, demand for health care workers and health care job openings were at record highs. We also know that the pandemic created pressure to quickly ramp up staffing levels and optimize surge capacity, even as the cancellation of non-emergent surgeries caused鈥
The Centers for Medicare & Medicaid Services (CMS) Oct. 8 announced new repayment terms for payments received under its Accelerated and Advance Payment (AAP) programs.
The AHA joined five other national medical groups in urging the Department of Homeland Security to exclude foreign national physicians in the J-1 visa program from a proposed change to the process for extending certain non-immigrant visa stays in the United States.
Among 767 hotspot counties for COVID-19 in June and July, early increases in the rate of positive test results for Americans under age 25 were followed by several weeks of rising positivity rates in older age groups, the Centers for Disease Control and Prevention reported.
The National Institutes of Health has launched a global clinical trial to test a potential COVID-19 treatment that combines remdesivir with a highly concentrated antibody solution.
A bipartisan group of 32 senators expressed concerns that the Department of Health and Human Services鈥 Sept. 19 change to COVID-19 Provider Relief Fund reporting requirements will create uncertainty and financial hardship for hospitals, particularly those in rural areas.